Great Point Partners, LLC

About The Fund

Great Point Partners, LLC is a private equity fund based in Greenwich, Connecticut, with a focus on investment opportunities across the healthcare sector. With assets under management amounting to $1 billion, they are dedicated to funding transformational health care companies. The firm employs a dual strategy approach, engaging with lower middle market growth buyout funds investing in private healthcare companies, as well as a hedge fund investing in public life sciences companies. Founded in 2003, Great Point Partners aims to assist growing healthcare organizations in reaching their full potential while enhancing global healthcare outcomes. Leveraging over 100 years of combined industry experience and a team of more than 30 professionals, Great Point Partners looks for profitable healthcare entities with management teams eager for accelerated and sustainable expansion. Their private equity investments usually range between $7 million and $25 million, focusing on areas such as Expansion, MBO/LBO, Acquisition, Recapitalization, PIPE, Corporate Divestiture, and Spinout. Their BioMedical Value Fund (BMVF) targets investments in small to mid-capitalization, publicly traded biotechnology and life sciences companies, looking to back revolutionary technology that promises to radically improve disease management and treatment. The BMVF's investment decisions are informed by the insight of MDs, PhDs, and PharmDs through a fundamentally focused, deep value investment methodology, aiming to pinpoint asymmetric risk-reward dynamics within the publicly traded life sciences landscape. Companies often choose to partner with Great Point Partners due to their healthcare expertise, industry connections, and commitment to fostering growth in concert with strong management teams. The firm operates with a partnership philosophy, intending to support innovation in drug development and growth within the healthcare sector.